Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Equity (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Equity for 6 consecutive years, with 0.75% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 19.0% to 0.75% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.75%, a 19.0% decrease, with the full-year FY2024 number at 0.48%, down 17.0% from a year prior.
  • Return on Equity was 0.75% for Q3 2025 at Caribou Biosciences, down from 0.65% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.27% in Q1 2021 to a low of 0.75% in Q3 2025.
  • A 5-year average of 0.24% and a median of 0.35% in 2021 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: plummeted -215bps in 2021, then grew 7bps in 2022.
  • Caribou Biosciences' Return on Equity stood at 0.17% in 2021, then plummeted by -102bps to 0.34% in 2022, then increased by 11bps to 0.3% in 2023, then crashed by -106bps to 0.62% in 2024, then fell by -21bps to 0.75% in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Return on Equity are 0.75% (Q3 2025), 0.65% (Q2 2025), and 0.51% (Q1 2025).